Activation of hypothalamic serotonin receptors reduced intake of dietary fat and protein but not carbohydrate

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 277, Issue 3 46-3, 1999, Pages

  Smith, Brenda K ^a   York, David A ^a,b   Bray, George A ^a,b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 hydroxytryptamine; Fenfluramine; Food intake; Paraventricular nucleus; Preference; Quipazine

Indexed keywords

DEXFENFLURAMINE; FLUOXETINE; METERGOLINE; NORFENFLURAMINE; QUIPAZINE; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CARBOHYDRATE INTAKE; FAT INTAKE; FOOD PREFERENCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; RAT; SEROTONINERGIC SYSTEM; THALAMUS MIDLINE NUCLEUS;

EID: 0032881287     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.277.3.r802     Document Type: Article

References (49)

1. Blundell, J. E., C. L. Lawton, and J. C. G. Halford. Serotonin, eating behavior, and fat intake. Obes. Res. 3, Suppl. 4: 471S-476S, 1995.
2. Boeles, S., C. Williams, G. M. Campling, E. M. Goodall, and P. J. Cowen. Sumatriptan decreases food intake and increases plasma growth hormone in healthy women. Psychopharmacology (Berl.) 129: 179-182, 1997.
3. 1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33: 367-386, 1994.
4. Clandinin, M. T., M. Suh, and K. Hargreaves. Impact of dietary fatty acid balance on membrane structure and function of neuronal tissues. Adv. Exp. Med. Biol. 318: 197-210, 1992.
5. Coscina, D. V., D. Feifel, J. N. Nobrega, and P. J. Currie. Intraventricular but not intraparaventricular nucleus metergoline elicits feeding in satiated rats. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1562-R1567, 1994.
6. Fletcher, P. Increased food intake in satiated rats induced by the 5-HT antagonists methysergide, metergoline and ritanserin. Psychopharmacology (Berl.) 96: 237-242, 1988.
7. Fletcher, P., and I. A. Paterson. A comparison of the effects of tryptamine and 5-hydroxytryptamine on feeding following injection into the paraventricular nucleus of the hypothalamus. Pharmacol. Biochem. Behav. 32: 907-911, 1989.
8. Garattini, S. Biological actions of drugs affecting serotonin and eating. Obes. Res. 3, Suppl. 4: 463S-470S, 1995.
9. Gibson, E. L., A. J. Kennedy, and G. Curzon. D-Fenfluramine- and D-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors. Eur. J. Pharmacol. 242: 83-90, 1993.
10. Goodall, E. M., P. J. Cowen, M. Franklin, and T. Silverstone. Ritanserin attenuates anorectic, endocrine and thermic responses to D-fenfluramine in human volunteers. Psychopharmacology (Berl.) 112: 461-466, 1993.
11. Grignaschi, G., and R. Samanin. Role of 5-HT receptors in the effect of D-fenfluramine on feeding patterns in the rat. Eur. J. Pharmacol. 212: 287-289, 1992.
12. 1B receptor mediates the effect of D-fenfluramine on eating caused by intra-hypothalamic injection of neuropeptide Y. Eur. J. Pharmacol. 274: 221-224, 1995.
13. Hawkins, M. F., C. A. Barkemeyer, and R. T. Tulley. Synergistic effects of dopamine agonists and centrally administered neurotensin on feeding. Pharmacol. Biochem. Behav. 24: 1195-1201, 1986.
14. Heisler, L. K., R. B. Kanarek, and A. Gerstein. Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats. Pharmacol. Biochem. Behav. 58: 767-773, 1997.
15. Hutson, P. H., T. B. Donohoe, and G. Curzon. Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology (Berl.) 95: 550-552, 1988.
16. Kanarek, R. B., and H. Dushkin. Peripheral serotonin administration selectively reduces fat intake in rats. Pharmacol. Biochem. Behav. 31: 113-122, 1988.
17. Kanarek, R. B., A. L. Glick, and R. Marks-Kaufman. Dietary influences on the acute effects of anorectic drugs. Physiol. Behav. 49: 149-152, 1991.
18. Lafreniere, F., J. Lambert, E. Rasio, and O. Serri. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. Int. J. Obes. 17: 25-30, 1993.
19. Lawton, C. L., and J. E. Blundell. 5-HT manipulation and dietary choice: variable carbohydrate (Polycose) suppression demonstrated only under specific experimental conditions. Psychopharmacology (Berl.) 112: 375-382, 1993.
20. Lawton, C. L., and J. E. Blundell. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of D-fenfluramine and DOI. Pharmacol. Biochem. Behav. 46: 349-360, 1993.
21. 1B) agonist CP-93,129 into the parabrachial nucleus potently and selectively reduces food intake in rats. Psychopharmacology (Berl.) 136: 304-307, 1998.
22. Lehr, D., and W. Goldman. Continued pharmacologic analysis of consummatory behavior in the albino rat. Eur. J. Pharmacol. 23: 197-210, 1973.
23. Leibowitz, S. F., J. T. Alexander, W. K. Cheung, and G. F. Weiss. Effects of serotonin and the serotonin blocker metergoline on meal patterns and macronutrient selection. Pharmacol. Biochem. Behav. 45: 185-194, 1993.
24. Leibowitz, S. F., G. F. Weiss, and G. Shor-Posner. Hypothalamic serotonin: pharmacological, biochemical, and behavioral analyses of its feeding-suppressive action. Clin. Neuropharmacol. 11, Suppl. 1: S51-S71, 1988.
25. Leibowitz, S. F., G. F. Weiss, and J. S. Suh. Medial hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behavior. Pharmacol. Biochem. Behav. 37: 735-742, 1990.
26. Leibowitz, S. F., G. F. Weiss, U. A. Walsh, and D. Viswanath. Medial hypothalamic serotonin: role in circadian patterns of feeding and macronutrient selection. Brain Res. 503: 132-140, 1989.
27. Lin, L., and D. A. York. Metergoline blocks the feeding response to enterostatin (Abstract). Appetite 23: 313, 1994.
28. Lin, L., and D. A. York. Chronic ingestion of dietary fat is a prerequisite for inhibition of feeding by enterostatin. Am. J. Physiol. 275 (Regulatory Integrative Comp. Physiol. 44): R619-R623, 1998.
29. Lucas, J. J., A. Yamamoto, K. Scearce-Levie, F. Saudou, and R. Hen. Absence of fenfluramine-induced anorexia and reduced c-fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. J. Neurosci. 18: 5537-5544, 1998.
30. Luo, S., and E. T. S. Li. Effects of repeated administration of serotonergic agonists on diet selection and body weight in rats. Pharmacol. Biochem. Behav. 38: 495-500, 1991.
31. 1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. J. Med. Chem. 33: 2087-2093, 1990.
32. Max, J. P., P. Thystere, M. Chapleur-Chateau, A. Burlet, J. P. Nicolas, and C. Burlet. Hypothalamic neuropeptides could mediate the anorectic effects of fenfluramine. Neuroreport 5: 1925-1928, 1994.
33. Mennini, T., A. Bizzi, S. Caccia, A. Codegoni, C. Fracasso, E. Frittoli, G. Guiso, I. M. Padura, C. Taddei, A. Uslenghi, et al. Comparative studies on the anorectic activity of D-fenfluramine in mice, rats and guinea pigs. Naunyn Schmiedebergs Arch. Pharmacol. 343: 483-490, 1991.
34. Muldoon, M. F., J. R. Kaplan, S. B. Manuck, and J. J. Mann. Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol. Psychiatry 31: 739-742, 1992.
35. Mullen, B. J., and R. J. Martin. The effect of dietary fat on diet selection may involve central serotonin. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R559-R563, 1992.
36. Orthen-Gambill, N., and R. B. Kanarek. Differential effects of amphetamine and fenfluramine on dietary self-selection in rats. Pharmacol. Biochem. Behav. 16: 303-309, 1982.
37. Pandey, G. N. Altered serotonin function in suicide: evidence from platelet and neuroendocrine studies. Ann. NY Acad. Sci. 836: 182-200, 1997.
38. Rowland, N. E., S. M. Antelman, and T. J. Bartness. Comparison of the effects of fenfluramine and other anorectic agents in different feeding and drinking paradigms in rats. Life Sci. 36: 2295-2300, 1985.
39. Sawchenko, P. E., L. W. Swanson, H. W. M. Steinbusch, and A. A. J. Verhofstad. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 277: 355-360, 1983.
40. 1B receptor ligands exist? Naunyn Schmiedebergs Arch. Pharmacol. 339: 675-683, 1989.
41. Shor-Posner, G., J. A. Grinker, C. Marinescu, O. Brown, and S. F. Leibowitz. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res. Bull. 17: 663-671, 1986.
42. 2 receptor mediation in quipazine anorexia. Psychopharmacology (Berl.) 100: 115-118, 1990.
43. Smith, B. K., D. A. York, and G. A. Bray. Chronic D-fenfluramine treatment reduces fat intake independent of macronutrient preference. Pharmacol. Biochem. Behav. 60: 105-114, 1998.
44. Stallone, D., and S. Nicolaidis. Increased food intake and carbohydrate preference in the rat following treatment with the serotonin antagonist metergoline. Neurosci. Lett. 102: 319-324, 1989.
45. Weiss, G. F., N. Rogacki, A. Fueg, D. Buchen, and S. F. Leibowitz. Impact of hypothalamic D-norfenfluramine and peripheral D-fenfluramine injection on macronutrient intake in the rat. Brain Res. Bull. 25: 849-859, 1990.
46. 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351: 357-373, 1995.
47. Wurtman, J. J., and R. J. Wurtman. Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats. Science 198: 1178-1180, 1977.
48. Wurtman, J. J., and R. J. Wurtman. Carbohydrate craving, obesity and brain serotonin. Appetite 7, Suppl.: 99-103, 1986.
49. York, D. A., J. Waggener, and G. A. Bray. Brain amine responses to peripheral enterostatin (Abstract). Int. J. Obes. 18: 102, 1994.